Four new dimeric bis(BF(2))-2,2'-bidipyrrins (bisBODIPYs), and their corresponding BODIPY monomers, have been prepared and studied with respect to their structural and photophysical properties. The solid-state molecular structure of the dimers and the relative orientation of the subunits have been revealed by an X-ray diffraction study, which showed that the molecules contain two directly linked BODIPY chromophores in a conformationally fixed, almost orthogonal arrangement. Two of the fluorine atoms are in close contact with each other and the (19)F NMR spectra show a characteristic through-space coupling in solution. The new chromophores all exhibit a clear exciton splitting in the absorption spectra with maxima at about 490 and 560 nm, and are highly luminescent with an intense emission band at around 640 nm. The Stokes shift, which is the difference between the maximum of the lowest-energy absorption band and the maximum of the emission band, has a typical value of 5 to 15 nm for simple BODIPYs, whereas this value increases to 80 nm or more for the dimers, along with a slight decrease in fluorescence quantum yields and lifetimes. These properties indicate potential uses of these new fluorophoric materials as functional dyes in biomedical and materials applications and also in model compounds for BODIPY aggregates.

Purpose: A Phase I/IIb multicenter study was conducted to evaluate the safety and immunogenicity of the anti-idiotypic antibody vaccine ACA125 that functionally imitates the tumor antigen CA125 in 119 patients with advanced ovarian carcinoma. A preliminary report on the initial 42 patients demonstrated safety and immunogenicity.Experimental Design: Using the complete intention-totreat population (n ‫؍‬ 119) who received a mean of 9.7 ACA125 applications, survival was analyzed with respect to immunological responses.Results : Conclusions: Although the uncontrolled design of this study prevents definitive conclusions with respect to subgroups, the data support a relationship between Ab3 response and survival time. Thus, the need for further randomized, controlled clinical trials to establish efficacy of the vaccine ACA125 seems to be indicated.

No abstract

Unsymmetrical 1-(arylimino)-3-(2-hetarylimino)isoindolines have been prepared from 1,3-diiminoisoindoline, an arylamine (aniline, 2-methylaniline, 2-iodoaniline), and a heteroaromatic amine (2-amino-6-methylpyridine, 2-amino-4-methylthiazole) in a stepwise manner by two consecutive condensations. The metalation reactions of these compounds with palladium(II) acetate proceed upon cyclopalladation of the carbocyclic aryl moieties and yield unsymmetrical C, N, N pincer complexes in all cases. X-ray crystallographic analysis were performed on single crystals of hydrogen{acetato[1-phenylimino-3-(6-methylpyridylimino)isoindolinato]palladate(II)} H[(phpi)Pd(OAc)] and pyridine[1-(2-tolylimino)-3-(4-methylthiazolylimino)isoindolinato]palladium(II) [(2-tolti)Pd(py)] by which the coordination mode, the conformation, the protonation site, and the trans influence of the carbon donor were established. For one more C, N, N pincer complex, hydrogen{acetato[1-(2-iodophenylimino)-3-(6-methylpyridylimino)isoindolinato]palladate(II)} H[(2-Iphpi)Pd(OAc)], a similar mononuclear coordination mode was confirmed by (1)H NMR spectroscopy, whereas for the product of an oxidative addition reaction of a palladium(0) precursor to the iodoaryl derivative a product with exo coordination was found. First experiments showed the effectivity of one of these complexes as a precatalyst in CC coupling reactions (Heck and Stille coupling).

We have generated an immunoglobulin G1 (IgG1) murine monoclonal anti-idiotype antibody (Ab2) designated ACA125, which mimics a specific epitope on the tumor-associated antigen CA125. This antigen is expressed by most of malignant ovarian tumors. Patients with CA125-positive tumors are immunologically tolerant to CA125. We used ACA125 as a surrogate for the tumor-associated antigen CA125 for vaccine therapy of 16 patients with advanced epithelial ovarian cancer or recurrences. Each of the patients received a minimum of 3 injections up to 19 injections of the complete anti-idiotype MAb ACA125 at a dosage of 2 mg per injection. Nine of 16 patients developed anti-anti-idiotypic (Ab3) responses to the ACA125. All 9 patients generated specific anti-CA125 antibody demonstrated by reactivity with purified CA125. Nine of 16 patients developed a CA125-specific cellular immune response by their peripheral blood lymphocytes (PBL) and 3 of 16 showed an increase in gamma-interferon concentrations accompanied by Ab3 responses. Toxicity was limited to abdominal pain in one case, which led to the withdrawal of further immunizations. The median progression free survival in those patients, who showed a specific immune response to the tumor-associated antigen CA125, was 11.0 +/- 5.6 months without any other therapy, in contrast to 8.0 +/- 4.2 months in the anti-anti-idiotype negative group. This is the first report of the induction of a specific active immunity to the tumor-associated antigen CA125 in patients with advanced ovarian cancer treated with an anti-idiotype antibody that "mimics" CA125. Patients showed the development of a specific humoral and cellular immune response to an otherwise nonimmunogenic tumor antigen. The immune responses in patients treated with this anti-idiotype vaccine, the low rate of side effects, and the improved time to progression after the induction of a specific immune response against the tumor-associated antigen CA125 justify follow-up clinical trials in advanced ovarian cancer patients with minimal residual disease in an adjuvant approach.

A unique series of halogenidoiron(III) complexes of the open-chain tetrapyrrolic ligand 2,2'-bidipyrrin (bpd) ([FeX(bdp)] X=F, Cl, Br, I) was prepared from simple pyrrolic and bipyrrolic precursors and iron chloride by a one-pot condensation/metalation strategy, followed by salt metathesis with CsF, LiBr, or NaI. Crystallographic analysis revealed that in all cases the 2,2'-bidipyrrin ligand is forced to reside in a helical conformation when bound to the iron atom. Whereas the extremely sensitive fluorido derivative was isolated as a CsF adduct and forms 1D polymeric chains in the solid state, the more stable chlorido, bromido, and iodido derivatives crystallize as discrete monomeric molecules with a distorted pentacoordinate iron(III) ion in an intermediate spin ground state. Magnetic susceptibility measurements and Mössbauer data of the compounds are in agreement with this interpretation. In solution, however, all the compounds are pentacoordinate with the iron atom in the high-spin (S=5/2) state and dynamic with respect to helix inversion. In the presence of air, the iron chelates react stepwise with the nucleophiles methanol and imidazolate at the tetrapyrrole terminal alpha,omega-positions, presumably through the hexacoordinate species [Fe(bdp)(MeOH)2]+ and [Fe(im)2-(bdp)](-), respectively. The successive increase of strain at these positions results in increasingly labile intermediates that spontaneously release the iron ion from the mono- or disubstituted tetrapyrrole ligands.

No abstract

Four (µ-oxido)diiron(III) complexes of differently alkyl-substituted 2,2Ј-bidipyrrin ligands [(L)Fe] 2 O have been prepared by a one-pot approach from the respectively substituted 2,2Ј-bipyrroledialdehydes and 3,4-dialkylpyrroles, and from a suitable source of trivalent iron, under alkaline conditions. Four single-crystal X-ray diffraction studies were undertaken on three of the new compounds as different solvates. The iron atoms are five-coordinate in all cases, and the observed Fe-N and Fe-O distances are in the range of 2.024-2.082 Å and 1.761-1.818 Å, respectively. These bonds are (porphyrinato)iron-like, typical for high spin iron(III) complexes, and clearly distinct from those observed for the respective mononuclear (chlorido)-, (bromido)-and (iodido)iron(III)-2,2Ј-bidipyrrins, which contain a central intermediate spin iron(III) ion in the solid state. All complexes contain two helically distorted tetrapyrrolic ligands with the same sense of helicity, but pack quite differently from one case to the other.